These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 37062280)
41. Trends in opioid use disorder and overdose among opioid-naive individuals receiving an opioid prescription in Massachusetts from 2011 to 2014. Burke LG; Zhou X; Boyle KL; Orav EJ; Bernson D; Hood ME; Land T; Bharel M; Frakt AB Addiction; 2020 Mar; 115(3):493-504. PubMed ID: 31691390 [TBL] [Abstract][Full Text] [Related]
42. Exploring opioid use disorder, its impact, and treatment among individuals experiencing homelessness as part of a family. Chatterjee A; Yu EJ; Tishberg L Drug Alcohol Depend; 2018 Jul; 188():161-168. PubMed ID: 29778009 [TBL] [Abstract][Full Text] [Related]
43. Opioid analgesic prescribing for opioid-naïve individuals prior to identification of opioid use disorder in British Columbia, Canada. Enns B; Krebs E; Thomson T; Dale LM; Min JE; Nosyk B Addiction; 2021 Dec; 116(12):3422-3432. PubMed ID: 33861882 [TBL] [Abstract][Full Text] [Related]
44. Physical therapists should play a greater role in managing patients with opioid use and opioid misuse. Magel J; Kietrys D; Kruger ES; Fritz JM; Gordon AJ Subst Abus; 2021; 42(3):255-260. PubMed ID: 34524070 [TBL] [Abstract][Full Text] [Related]
45. Self-reported challenges obtaining ongoing prescription opioids among Australians with chronic non-cancer pain. Hopkins RE; Campbell G; Degenhardt L; Lintzeris N; Larance B; Nielsen S; Gisev N Int J Drug Policy; 2022 Jul; 105():103708. PubMed ID: 35544972 [TBL] [Abstract][Full Text] [Related]
46. Patient Barriers and Facilitators to Medications for Opioid Use Disorder in Primary Care. Tofighi B; Williams AR; Chemi C; Suhail-Sindhu S; Dickson V; Lee JD Subst Use Misuse; 2019; 54(14):2409-2419. PubMed ID: 31429351 [No Abstract] [Full Text] [Related]
47. Trajectories of Opioid Misuse and Opioid Use Disorder Among Adults With Chronic Pain and HIV: An Observational Study. Perez HR; Deng Y; Zhang C; Groeger JL; Glenn M; Richard E; Pazmino A; De La Cruz AA; Prinz M; Starrels JL J Addict Med; 2024 Mar-Apr 01; 18(2):174-179. PubMed ID: 38270205 [TBL] [Abstract][Full Text] [Related]
48. Acute Pain and Development of Opioid Use Disorder: Patient Risk Factors. Baumann L; Bello C; Georg FM; Urman RD; Luedi MM; Andereggen L Curr Pain Headache Rep; 2023 Sep; 27(9):437-444. PubMed ID: 37392334 [TBL] [Abstract][Full Text] [Related]
49. Inequities in access to primary care among opioid recipients in Ontario, Canada: A population-based cohort study. Gomes T; Campbell TJ; Martins D; Paterson JM; Robertson L; Juurlink DN; Mamdani M; Glazier RH PLoS Med; 2021 Jun; 18(6):e1003631. PubMed ID: 34061846 [TBL] [Abstract][Full Text] [Related]
50. People with arthritis-disability and provider experiences with chronic opioid therapy: A qualitative inquiry. Paez KA; Lavelle ME; Lin A Disabil Health J; 2022 Jun; 15(2S):101294. PubMed ID: 35422404 [TBL] [Abstract][Full Text] [Related]
52. "Chasing the pain relief, not the high": Experiences managing pain after opioid reductions among patients with HIV and a history of substance use. Behar E; Bagnulo R; Knight K; Santos GM; Coffin PO PLoS One; 2020; 15(3):e0230408. PubMed ID: 32210442 [TBL] [Abstract][Full Text] [Related]
53. Reasons for opioid use among patients with dependence on prescription opioids: the role of chronic pain. Weiss RD; Potter JS; Griffin ML; McHugh RK; Haller D; Jacobs P; Gardin J; Fischer D; Rosen KD J Subst Abuse Treat; 2014 Aug; 47(2):140-5. PubMed ID: 24814051 [TBL] [Abstract][Full Text] [Related]
54. Pain Management Considerations in Patients With Opioid Use Disorder Requiring Critical Care. Smith K; Wang M; Abdukalikov R; McAullife A; Whitesell D; Richard J; Sauer W; Quaye A J Clin Pharmacol; 2022 Apr; 62(4):449-462. PubMed ID: 34775634 [TBL] [Abstract][Full Text] [Related]
55. Can the type of subjective response to first opioid exposure predict the risk of opioid use disorder? A scoping review. Morris CJ; Mills-Huffnagle S; Zgierska AE Brain Res Bull; 2022 Oct; 188():67-76. PubMed ID: 35901984 [TBL] [Abstract][Full Text] [Related]
56. Salivary measurement and mindfulness-based modulation of prescription opioid cue-reactivity. Hanley AW; Garland EL Drug Alcohol Depend; 2020 Dec; 217():108351. PubMed ID: 33070057 [TBL] [Abstract][Full Text] [Related]
57. Opioid prescription patterns in Germany and the global opioid epidemic: Systematic review of available evidence. Rosner B; Neicun J; Yang JC; Roman-Urrestarazu A PLoS One; 2019; 14(8):e0221153. PubMed ID: 31461466 [TBL] [Abstract][Full Text] [Related]
58. Beliefs and attitudes about opioid prescribing and chronic pain management: survey of primary care providers. Jamison RN; Sheehan KA; Scanlan E; Matthews M; Ross EL J Opioid Manag; 2014; 10(6):375-82. PubMed ID: 25531955 [TBL] [Abstract][Full Text] [Related]
60. Family member opioid prescriptions and opioid use disorder. Ali MM; Henke RM; Mutter R; O'Brien PL; Cutler E; Mazer-Amirshahi M; Pines JM Addict Behav; 2019 Aug; 95():58-63. PubMed ID: 30849719 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]